- Jun 19, 2018

Pediatric Cancer Trials: Is There A Solution?

Why is it so hard to develop drugs for children with cancer? And what can be done about it? Those questions are central to a new study published in JAMA Oncology that explores new business models for funding drug development to treat pediatric cancers.

Drug Offers Long-Term Heart Protection for Childhood Cancer Survivors

World-first guidelines created to prevent heart complications in children during cancer treatment

Patient Activated Education Effective as Surveillance for Skin Cancer in Childhood Cancer Survivors

Childhood, Adolescent Cancers Linked to Higher Risk of Major Psychiatric Disorders

Low BMD, fracture risk upped in childhood cancer survivors

Understanding How Childhood Brain Tumors Develop

American Academy of Pediatrics Issues New Recommendations on Hospitalized Adolescents

Genes that cause rare hidden cancer revealed

Stopping a rare childhood cancer in its tracks

Pediatric Cancer Vaccine May Be ‘Too Good to Be True,’ But More Work Is Needed

Recent Posts

Pediatric Cancer Trials: Is There A Solution?

Archive

Search By Tags